Changing the Future of Wound Care with Copper

Changing the Future of Wound Care with Copper

Copper dressings are driving a true revolution in wound care, delivering continuous, non-depleting antimicrobial protection with proven antibacterial, antiviral, and antifungal activity against a broad spectrum of pathogens. These advanced dressings support extended wear time of up to 7 days, reducing dressing changes while maintaining consistent protection, and are designed with irritant-free biocompatibility for patient comfort. As the only FDA-cleared copper-impregnated dressing, MedCu sets a new standard in advanced wound care. See case studies below:

A New Standard in Wound Care Overview

MedCu copper dressings have demonstrated exceptional performance in hard-to-heal wounds, including stalled wounds and wounds challenged by antibiotic-resistant pathogens, where conventional approaches often fail.


Wound Types Supported by Copper Dressings

This is a partial list and not exhaustive.

Recurrent wounds
Traumatic wounds
Venous leg ulcers
Diabetic foot ulcers
Chronic non-healing wounds
Wounds with high bioburden
Hard-to-heal and stalled wounds
Infected or infection-prone wounds
Ulcers associated with poor circulation
Surgical wounds and post-operative incisions
1st and 2nd degree burns and donor sites


Supported by scientific evidence and real-world case studies, these advanced copper-oxide dressings help create a wound environment that actively supports healing in scenarios where legacy wound care technologies fall short. MedCu represents a powerful option for complex, high-risk, and difficult wound care scenarios.

Our advanced wound care portfolio is built on more than 15 years of scientific research and development and is protected by over 30 patents worldwide. These FDA-cleared copper-oxide antimicrobial dressings represent a true departure from traditional wound care technologies and are supported by peer-reviewed studies and documented clinical outcomes across multiple high-risk patient populations.

Copper is permanently embedded within the dressing matrix, creating continuous, non-depleting antimicrobial activity throughout the full wear time. This mechanism delivers broad-spectrum efficacy against bacteria, viruses, and fungi, including antibiotic-resistant organisms such as MRSA and VRE. Unlike surface coatings or topical agents, copper’s antimicrobial activity does not diminish with moisture, exposure, or time and does not rely on antibiotics or chemical biocides.

These dressings have been used in multiple clinical studies and real-world cases after all traditional wound healing treatments failed. Documented outcomes include closure of wounds stalled for decades, including a 30-year non-healing wound, successful limb salvage in patients facing imminent amputation, and accelerated healing in complex diabetic wounds where infection control is critical to survival and function.

Additional evidence supports use in 1st and 2nd degree burns and donor site management, where copper’s ability to suppress microbial bioburden while supporting tissue regeneration is essential. Unlike some commonly used antimicrobial agents such as silver, copper is safe and non-toxic to human tissue at therapeutic levels and does not inhibit cell proliferation or delay healing, making it appropriate for prolonged and repeated use.

Copper’s safety and biocompatibility profile has been extensively studied beyond healthcare, including its incorporation into advanced textiles designed for prolonged skin contact and infection control, such as garments evaluated in NASA-supported research. This further supports copper’s versatility and safety for use on virtually any area of the body, including sensitive, high-friction, and moisture-prone regions.

The versatility of copper-oxide dressings allows for application across acute, post-acute, outpatient, and home care settings, addressing a wide spectrum of wounds without the limitations associated with toxic or short-acting antimicrobial technologies. Extended wear time of up to 7 days reduces dressing changes, minimizes disruption to healing tissue, and supports improved clinical and patient-care outcomes.


 

Clinical Evidence & Case Study Reviews

The effectiveness of copper-oxide dressings is supported by peer-reviewed research and documented clinical outcomes in complex wound care scenarios where conventional treatments were unsuccessful. Below are selected case study reviews demonstrating real-world application and outcomes.

The following case studies may include clinical descriptions and imagery related to wound care that some viewers may find sensitive. Viewer discretion is advised.

Case Study Review 1
Reducing Chronic Inflammation
View Case Study Here


Case Study Review 2
Copper Dressings Prevents Amputation
View Case Study Here


Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare professional regarding any medical condition or wound care decision.
Individual results may vary. Outcomes described are based on clinical studies, case reports, and real-world use and may not be representative of all patients. MedCu copper-oxide dressings are FDA-cleared medical devices and should be used in accordance with their indicated use and applicable clinical guidelines.